{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:00:18Z","timestamp":1792501218511,"version":"4.5.0"},"reference-count":42,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T00:00:00Z","timestamp":1611964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cancer treatments can often adversely affect the quality of life of young women. One of the most relevant negative impacts is the loss of fertility. Cyclophosphamide is one of the most detrimental chemotherapeutic drugs for the ovary. Cyclophosphamide may induce the destruction of dormant follicles while promoting follicle activation and growth. Herein, we demonstrate the in vivo protective effect of the allosteric Bcr-Abl tyrosine kinase inhibitor Asciminib on signaling pathways activated by cyclophosphamide in mouse ovaries. We also provide evidence that Asciminib does not interfere with the cytotoxic effect of cyclophosphamide in Michigan Cancer Foundation (MCF)7 breast cancer cells. Our data indicate that concomitant administration of Asciminib mitigates the cyclophosphamide-induced ovarian reserve loss without affecting the anticancer potential of cyclophosphamide. Taken together, these observations are relevant for the development of effective ferto-protective adjuvants to preserve the ovarian reserve from the damaging effects of cancer therapies.<\/jats:p>","DOI":"10.3390\/ijms22031395","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T08:56:01Z","timestamp":1611996961000},"page":"1395","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Asciminib Mitigates DNA Damage Stress Signaling Induced by Cyclophosphamide in the Ovary"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3543-977X","authenticated-orcid":false,"given":"Luca","family":"Mattiello","sequence":"first","affiliation":[{"name":"Department of Biology, University of Rome Tor Vergata, via della Ricerca Scientifica, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pucci","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Rome Tor Vergata, via della Ricerca Scientifica, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marchetti","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Rome Tor Vergata, via della Ricerca Scientifica, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Diederich","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9392-4258","authenticated-orcid":false,"given":"Stefania","family":"Gonfloni","sequence":"additional","affiliation":[{"name":"Department of Biology, University of Rome Tor Vergata, via della Ricerca Scientifica, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.23071","article-title":"Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function","volume":"110","author":"Oktem","year":"2007","journal-title":"Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/GRF.0b013e3181f96b54","article-title":"Toxicity of Chemotherapy and Radiation on Female Reproduction","volume":"53","author":"Meirow","year":"2010","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.juro.2016.09.159","article-title":"Fertility Preservation for Pediatric Patients: Current State and Future Possibilities","volume":"198","author":"Johnson","year":"2017","journal-title":"J. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/humupd\/dmh021","article-title":"Fertility preservation in female patients","volume":"10","author":"Sonmezer","year":"2004","journal-title":"Hum. Reprod. Update"},{"key":"ref_5","first-page":"185ra62","article-title":"Cyclophosphamide Triggers Follicle Activation and \"Burnout\"; AS101 Prevents Follicle Loss and Preserves Fertility","volume":"5","author":"Roness","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-1961-y","article-title":"Kinase-independent inhibition of cyclophosphamide-induced pathways protects the ovarian reserve and prolongs fertility","volume":"10","author":"Bellusci","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1530\/JOE-18-0370","article-title":"Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide","volume":"240","author":"Luan","year":"2019","journal-title":"J. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/molehr\/gaz020","article-title":"Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes","volume":"25","author":"Nguyen","year":"2019","journal-title":"Mol. Hum. Reprod."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.fertnstert.2015.11.043","article-title":"Prevention of chemotherapy-induced ovarian damage","volume":"105","author":"Roness","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/humupd\/dmu019","article-title":"Prevention of chemotherapy-induced ovarian damage: Possible roles for hormonal and non-hormonal attenuating agents","volume":"20","author":"Roness","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"E1688","DOI":"10.1073\/pnas.1620729114","article-title":"AMH\/MIS as a contraceptive that protects the ovarian reserve during chemotherapy","volume":"114","author":"Kano","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1096\/fj.201801089R","article-title":"AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice","volume":"33","author":"Sonigo","year":"2018","journal-title":"FASEB J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"29005","DOI":"10.1074\/jbc.M109.026633","article-title":"N-Myristoylated c-Abl Tyrosine Kinase Localizes to the Endoplasmic Reticulum upon Binding to an Allosteric Inhibitor","volume":"284","author":"Choi","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2217\/fon-2016-0176","article-title":"Chemotherapy-induced damage to ovary: Mechanisms and clinical impact","volume":"12","author":"Bedoschi","year":"2016","journal-title":"Future Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/humupd\/dms022","article-title":"How do chemotherapeutic agents damage the ovary?","volume":"18","author":"Morgan","year":"2012","journal-title":"Hum. Reprod. Update"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dmz027","article-title":"Ovarian damage from chemotherapy and current approaches to its protection","volume":"25","author":"Spears","year":"2019","journal-title":"Hum. Reprod. Update"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/molehr\/gaaa043","article-title":"Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: Road to developing therapeutics for fertility preservation and reversing ovarian aging","volume":"26","author":"Szymanska","year":"2020","journal-title":"Mol. Hum. Reprod."},{"key":"ref_18","first-page":"624","article-title":"p63 protects the female germ line during meiotic arrest","volume":"444","author":"Suh","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1530\/REP-07-0054","article-title":"p63 null mutation protects mouse oocytes from radio-induced apoptosis","volume":"135","author":"Livera","year":"2007","journal-title":"Reproduction"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.molcel.2012.08.017","article-title":"DNA Damage-Induced Primordial Follicle Oocyte Apoptosis and Loss of Fertility Require TAp63-Mediated Induction of Puma and Noxa","volume":"48","author":"Kerr","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.1247671","article-title":"Reversal of Female Infertility by Chk2 Ablation Reveals the Oocyte DNA Damage Checkpoint Pathway","volume":"343","author":"Rinaldi","year":"2014","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-0633-7","article-title":"Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility","volume":"9","author":"Nguyen","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41418-018-0151-2","article-title":"Transient inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by anticancer therapies","volume":"26","author":"Kim","year":"2019","journal-title":"Cell Death Differ."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nm.2033","article-title":"Inhibition of the c-Abl\u2013TAp63 pathway protects mouse oocytes from chemotherapy-induced death","volume":"15","author":"Gonfloni","year":"2009","journal-title":"Nat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/cdd.2013.31","article-title":"Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network","volume":"20","author":"Kim","year":"2013","journal-title":"Cell Death Differ."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1534\/genetics.117.203455","article-title":"Pharmacological Inhibition of the DNA Damage Checkpoint Prevents Radiation-Induced Oocyte Death","volume":"206","author":"Rinaldi","year":"2017","journal-title":"Genetics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm1009-1124","article-title":"Preserving fertility during cancer treatment","volume":"15","author":"Woodruff","year":"2009","journal-title":"Nat. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4161\/cc.9.2.10563","article-title":"Modulating c-Abl nuclear activity as a strategy to preserve female fertility","volume":"9","author":"Gonfloni","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1534\/genetics.120.303182","article-title":"Oocyte Elimination Through DNA Damage Signaling from CHK1\/CHK2 to p53 and p63","volume":"215","author":"Rinaldi","year":"2020","journal-title":"Genetics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/mrd.21326","article-title":"Protein tyrosine kinase signaling during oocyte maturation and fertilization","volume":"78","author":"McGinnis","year":"2011","journal-title":"Mol. Reprod. Dev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/683097","article-title":"Oxidative Stress, DNA Damage, and c-Abl Signaling: At the Crossroad in Neurodegenerative Diseases?","volume":"2012","author":"Gonfloni","year":"2012","journal-title":"Int. J. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1242\/jcs.175521","article-title":"Mutifunctional Abl kinases in health and disease","volume":"129","author":"Khatri","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nm.2852","article-title":"Reply to: Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib","volume":"18","author":"Maiani","year":"2012","journal-title":"Nat. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/cdd.2014.122","article-title":"Oocyte-specific inactivation of Omcg1 leads to DNA damage and c-Abl\/TAp63-dependent oocyte death associated with dramatic remodeling of ovarian somatic cells","volume":"22","author":"Vandormaelpournin","year":"2014","journal-title":"Cell Death Differ."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"106458","DOI":"10.1016\/j.leukres.2020.106458","article-title":"The specificity of asciminib, a potential treatment for chronic myeloid leukemia, as a myristate-pocket binding ABL inhibitor and analysis of its interactions with mutant forms of BCR-ABL1 kinase","volume":"98","author":"Manley","year":"2020","journal-title":"Leuk. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/1947601912462126","article-title":"The Ins and Outs of Bcr-Abl Inhibition","volume":"3","author":"Reddy","year":"2012","journal-title":"Genes Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nchembio760","article-title":"Allosteric inhibitors of Bcr-abl\u2013dependent cell proliferation","volume":"2","author":"Ding","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jmgm.2019.03.018","article-title":"Molecular dynamics investigation on the Asciminib resistance mechanism of I502L and V468F mutations in BCR-ABL","volume":"89","author":"Zhan","year":"2019","journal-title":"J. Mol. Graph. Model."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.1021\/acs.jmedchem.8b01040","article-title":"Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1","volume":"61","author":"Schoepfer","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_40","first-page":"733","article-title":"The allosteric inhibitor ABL001 enables dual targeting of BCR\u2013ABL1","volume":"543","author":"Wylie","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa1902328","article-title":"Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure","volume":"381","author":"Hughes","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e00273","DOI":"10.1002\/prp2.273","article-title":"Contribution of Sigma-1 receptor to cytoprotective effect of afobazole","volume":"4","author":"Voronin","year":"2016","journal-title":"Pharmacol. Res. Perspect."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/3\/1395\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:17:38Z","timestamp":1760159858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/3\/1395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,30]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["ijms22031395"],"URL":"https:\/\/doi.org\/10.3390\/ijms22031395","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.12.30.424825","asserted-by":"object"}]},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,30]]}}}